Delcath(DCTH)

Search documents
Delcath(DCTH) - 2023 Q3 - Quarterly Report
2023-11-12 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _____________________ FORM 10-Q ______________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-16133 DELCATH SYSTEMS, INC. (Exact name of regi ...
Delcath(DCTH) - 2023 Q2 - Quarterly Report
2023-08-08 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _____________________ FORM 10-Q ______________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-16133 DELCATH SYSTEMS, INC. (Exact name of registran ...
Delcath(DCTH) - 2023 Q1 - Quarterly Report
2023-05-21 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-16133 DELCATH SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 06-1245881 (State or other j ...
Delcath(DCTH) - 2023 Q1 - Earnings Call Transcript
2023-05-12 14:13
Delcath Systems Inc. (NASDAQ:DCTH) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ET Company Participants Gerard Michel - Chief Executive Officer Anthony Dias - Vice President, Finance Kevin Muir - General Manager, U.S. Interventional Oncology David Hoffman - General Counsel, Chief Compliance Officer Conference Call Participants Yale Jen - Laidlaw & Co. Swayampakula Ramakanth - HC Wainwright Bill Maughan - Canaccord Genuity Operator Good day and welcome to the Delcath Systems Reports First Quarter ...
Delcath(DCTH) - 2022 Q4 - Annual Report
2023-03-26 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2022 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission file number: 001-16133 DELCATH SYSTEMS, INC. Delaware 06-1245881 definitions of "large accelerated filer," "accelerated filer", "smaller reportin ...
Delcath(DCTH) - 2022 Q3 - Earnings Call Transcript
2022-11-08 18:33
Start Time: 08:30 January 1, 0000 9:00 AM ET Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2022 Earnings Conference Call November 08, 2022, 08:30 AM ET Company Participants Gerard Michel - CEO Anthony Dias - VP of Finance Johnny John - VP, Clinical Development & Medical Affairs Kevin Muir - VP, Commercial Operations David Hoffman - General Counsel, Corporate Secretary and Chief Compliance Officer Conference Call Participants Sam Eiber - BTIG Scott Henry - ROTH Capital Yale Jen - Laidlaw & Company Bill Maughan - Ca ...
Delcath(DCTH) - 2022 Q3 - Quarterly Report
2022-11-07 16:00
Table of Contents Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.01 par value per share DCTH The NASDAQ Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro ...
Delcath(DCTH) - 2022 Q2 - Earnings Call Transcript
2022-08-08 18:56
Delcath Systems, Inc. (NASDAQ:DCTH) Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET Company Participants David Hoffman - General Counsel Gerard Michel - Chief Executive Officer Anthony Dias - Vice President of Finance Johnny John - Senior Vice President of Medical Affairs and Clinical Development Kevin Muir - Vice President of Commercial Operations John Purpura - Chief Operating Officer Conference Call Participants Scott Henry - Roth Capital Marie Sebalt - BTIG Bill Maughan - Canaccord Genuity Ya ...
Delcath(DCTH) - 2022 Q2 - Quarterly Report
2022-08-07 16:00
Table of Contents Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.01 par value per share DCTH The NASDAQ Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ ...
Delcath(DCTH) - 2022 Q1 - Earnings Call Transcript
2022-05-10 19:13
Delcath Systems Ltd. (NASDAQ:DCTH) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants David Hoffman - General Counsel Gerard Michel - Chief Executive Officer Anthony Dias - Vice President of Finance Conference Call Participants Marie Thibault - BTIG Scott Henry - Roth Capital Partners Swayampakula Ramakanth - H.C. Wainwright Operator Good morning, ladies and gentlemen, and welcome to the Delcath’s First Quarter 2022 Earnings Call. At this time, all participants have been placed o ...